Screener
Cogent Biosciences, Inc. COGT Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s return on invested capital?
- Cogent Biosciences, Inc. (COGT) reported return on invested capital of -147.2% in Q1 2026.
- How has Cogent Biosciences, Inc.'s return on invested capital changed year-over-year?
- Cogent Biosciences, Inc.'s return on invested capital increased by 14.5% year-over-year, from -172.1% to -147.2%.
- What is the long-term trend for Cogent Biosciences, Inc.'s return on invested capital?
- Over 2 years (2023 to 2025), Cogent Biosciences, Inc.'s return on invested capital has grown at a 5.6% compound annual growth rate (CAGR), from -116% to -129.2%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Cogent Biosciences, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude